Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Amortizatization of Intangibles (2019 - 2025)

Marimed (MRMD) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 25.4% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.5 million, a 37.3% increase, with the full-year FY2024 number at $2.9 million, down 2.55% from a year prior.
  • Amortizatization of Intangibles was $2.4 million for Q3 2025 at Marimed, up from $117000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q3 2025 to a low of -$294000.0 in Q3 2021.
  • A 5-year average of $576210.5 and a median of $450000.0 in 2021 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 346.14% in 2021, then soared 657.14% in 2023.
  • Marimed's Amortizatization of Intangibles stood at $638000.0 in 2021, then crashed by 32.92% to $428000.0 in 2022, then increased by 8.88% to $466000.0 in 2023, then soared by 89.48% to $883000.0 in 2024, then skyrocketed by 168.4% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Amortizatization of Intangibles are $2.4 million (Q3 2025), $117000.0 (Q2 2025), and $105000.0 (Q1 2025).